# Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years

> **NCT05767606** · PHASE4 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 256 (estimated)

## Conditions studied

- COVID-19
- Pneumococcal Infections

## Interventions

- **BIOLOGICAL:** NVX
- **BIOLOGICAL:** PCV20
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05767606
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-03
- **Primary completion:** 2023-07
- **Final completion:** 2023-08
- **Target enrollment:** 256 (ESTIMATED)
- **Last updated:** 2023-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05767606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05767606, "Concomitant Administration of the Novavax Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05767606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*